Pfizer illustrates torcetrapib failure
Suggestions that Pfizer's scrapped cholesterol drug could actually make coronary artery disease worse could set hearts racing among others developing drugs in the same class.
Archives for March 27, 2007
Isis cholesterol drug makes sense
Antisense drug developers received a boost today with the news that Isis Pharmaceuticals' cholesterol lowering drug is showing good results in clinical trials.
Outsourcing key to manufacture 'combo products'
Outsourcing is key for pharma companies and medical device manufacturers keen to develop and produce "combination products" - medical devices embedded with a pharma component - according to an industry player.
FDA wants tougher conflict-of-interest test for advisers
The US Food and Drug Administration (FDA) has tackled escalating concerns about the independence of its advisory committees by proposing more stringent criteria for avoiding potential conflicts of interest when considering potential committee members.
EMEA adopts 'first-in-man' clinical trials guideline
The pan-European drug regulator, the European Medicines Agency (EMEA), has adopted a draft guideline for first-in-man clinical studies for potential high-risk drugs in a bid to prevent a repeat of last year's TGN1412 drug trial disaster in London.